Search

Darius Gambino has over 20 years of experience helping clients protect their intellectual property in the United States and abroad. Clients in industries ranging from technology and manufacturing to consumer goods and professional services rely on Darius to represent them in high stakes patent...

Real-World Data Privacy and Cybersecurity Counseling Information is a vitally important asset in today’s digital age. Companies are collecting and processing unprecedented amounts of data, much of which is sensitive employee and customer information. Often, companies rely upon the assistance of...

Jay Reilly represents biotech, medical device and diagnostic companies, as well as universities and nonprofits, in strategic transactions in the life sciences industry, particularly complex collaborative arrangements and technology acquisitions and dispositions. Jay has extensive experience...

Max Bremer advises entrepreneurs and established companies on key transactions throughout the business life cycle, from formations and financings to mergers, acquisitions and divestitures. Max works with clients in a variety of industries, including health care IT, medical devices, data analytics...

Doug Ramler's focus is on helping entrepreneurs, managers and boards build their companies. He advises high-growth start-up and emerging companies on business formation, technology commercialization, finance, governance, contracts and strategic matters. With 30 years of experience, Doug is able to...

Erik Kantz focuses his practice on middle-market businesses and emerging companies. Having served in both the business and litigation groups of the Firm, Erik takes a business approach to the practice of law, helping clients design and implement strategies and organizational structures that promote...

Counsel From the Earliest Stage of Development Through Disposition of Projects Throughout the continuum of financing, acquiring, developing, leasing and selling real estate are a multitude of complexities to address and challenges to overcome—from regulatory hurdles and shifting capital stacks to...